This announcement is a separate document:
长春百克生物科技股份公司监事会关于2022年限制性股票激励计划首次授予第一个归属期归属名单的核查意见
Opinions of the Supervisory Board of Changchun Baike Biotechnology Co., Ltd. on the verification of the 2022 Restricted Stock Incentive Plan for the first time granting an ownership list for the first vesting period
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.